Plain-English translation of NCT05142787 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new system called Magseed Pro® and Sentimag® Gen3 that uses tiny magnetic markers to help surgeons precisely locate and remove breast lesions or suspicious lymph nodes. Before surgery, a doctor places a small magnetic marker directly into the area that needs to be removed. During surgery, the surgeon uses a handheld detector to find the marker, which guides them to remove exactly the right tissue.
Currently, surgeons sometimes have difficulty pinpointing the exact location of small breast lesions or lymph nodes that need to be removed. This new magnetic marker system could make surgery more accurate, potentially reducing the amount of healthy tissue removed and improving surgical outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this study, a doctor will place the small magnetic marker into your breast lesion or lymph node using imaging guidance to ensure accuracy. You will then have surgery to remove the marked tissue, during which the surgeon uses the Sentimag® Gen3 detector to locate the marker. You will have follow-up visits over the next 1 to 38 weeks to monitor your recovery and ensure everything healed properly.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
Germany
United Kingdom